Alzheimer's Disease
11 competing products in clinical development for Alzheimer's Disease.
Pipeline by Phase
Phase 11
Phase 26
Phase 34
All Products (11)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LY450139 + Placebo | Eli Lilly | Phase 3 | Completed | 77 |
| Solanezumab + Placebo | Eli Lilly | Phase 3 | Terminated | 77 |
| Solanezumab + Placebo | Eli Lilly | Phase 3 | Terminated | 77 |
| Remternetug + Placebo | Eli Lilly | Phase 3 | Active | 77 |
| LY450139 dihydrate + placebo | Eli Lilly | Phase 2 | Completed | 52 |
| solanezumab | Eli Lilly | Phase 2 | Completed | 52 |
| GSK4527226 | Alector | Phase 2 | Active | 44 |
| GSK4527226 | Alector | Phase 2 | Recruiting | 44 |
| AL002 | Alector | Phase 2 | Terminated | 44 |
| simufilam | Cassava Sciences | Phase 2 | Terminated | 44 |
| LY2886721 + Placebo | Eli Lilly | Phase 1 | Completed | 33 |